Wana Brands’ leading edibles will enter Arizona, while AME’s MüV Line of medical cannabis products will launch in Colorado
Boulder, Colo.; Sarasota, Fla. (May 17, 2017) – Wana Brands and AltMed Enterprises announce the completion of licensing deals to bring Wana Brands’ top selling edibles to the Arizona market and AME’s award winning MüV line of medical cannabis infused products to the Colorado market. Wana Brands’ entry into the Arizona market will be through a licensing deal between its affiliate, Mountain High Infused Products, LLC and AltMed Arizona, an affiliate of AltMed Enterprises. A licensing agreement between NuTrae, LLC doing business as MüV (a subsidiary of AltMed Enterprises) and Wana Brands opens the door to MüV products becoming available in Colorado.
Award winning MϋV products are anticipated to be available in Colorado by Q4 2017, and Wana Brands’ popular cannabis-infused products are anticipated to be available in Arizona by Q4 2017.
“Medicinals are an important sector for Wana Brands, and we have seen the difference that products like WanaCapsXR can have for patients who are looking for relief that is consistent, discreet and reliable. Our licensing deal with MϋV to bring truly medicinal products—including transdermal patches and metered dose inhalers, that have been developed and tested for safety and consistency—to Colorado is the logical next step for us,” said Nancy Whiteman, Co-owner, Wana Brands.
“We have adopted a professional and scientific approach to the production of the highest quality medical cannabis products,” said AltMed Enterprises C.E.O Michael Smullen. “All our products are tested using methods from the American Herbal Pharmacopeia that exceed even the rigorous testing specifications established by more mature markets like Colorado. We are very excited to bring our high quality medical cannabis products to the patients of Colorado and further our mission to become the world’s leading medical cannabis brand through a licensing deal with a company like Wana Brands that shares our values in delivering only the highest quality products.”
The market for cannabis edibles has risen annually since Arizona legalized medical cannabis in 2010, with the medical market projected to hit $681 million by 2020, and edibles continue to be a popular item with patients. As consumers search for brands they can count on, Wana Brands will offer patients throughout Arizona a credible, consistent and potent product made from high quality ingredients.
Since AltMed Arizona introduced MϋV’s products in Arizona, MüV products have quickly gained wide reaching attention and recognition. MüV products have received four best of Arizona medical cannabis awards, including two first prizes for its proprietary ethanol extractions that are the foundation of the entire MüV product line.
“Wana Brands is known for its consistent quality as a national brand and perfectly aligns with MϋV’s mission,” said Karen Quick, Director, Commercial Operations for AltMed Enterprises. “Colorado is a leading market for the cannabis industry, but there are no other products that can meet MϋV product’s level of sophistication and patient-friendly delivery methods. We are looking forward to introducing our metered dose inhalers, transdermal patches and topical medical cannabis lines to the state.”
The MüV brand is fast becoming one of the world’s widest distributed medical cannabis brands. With recently signed deals, in addition to Arizona and Colorado, MüV products will soon be available in a number of U.S. states where medical cannabis is legal, including California, Washington, Oregon, Massachusetts and Nevada, and internationally, in Canada and Puerto Rico.
Wana Brands is Colorado’s No. 1 Edibles Brand, according to BDS Analytics, and produces 20,000 units a week in its 30,000 sq. ft. Colorado facility, servicing more than 450 of Colorado’s 500+ dispensaries. Wana Brands is also available in over 200 dispensaries in Oregon. In addition to launching in Nevada and now Arizona, the company has plans to bring its products to Illinois in 2017 and is in discussion with partners in several additional emerging markets. On Tuesday, June 13 at 2:45pm Whiteman will discuss emerging innovations and trends for infused product manufacturers in a session titled “Unveiling The Future: A New Crop of Infused Products” at the National Cannabis Industry Cannabis Business Summit and Expo (June 12-14, 2017, Oakland Marriott City Center, Oakland, California).
For more information on Wana Brands or to schedule an interview, please contact Shawna Seldon McGregor at 917 971 7852 or [email protected].
For more information on AltMed Enterprises and/or MüV or to schedule an interview, please contact Todd Beckwith at 941.225.2629 or [email protected].
Wana Brands: Enhance Your Life. Wana Brands leads the Cannabis infused products industry in quality, consistency and potency. Wana products include a full line of edibles, including our market leading gummies and WanaCapsxr, a family of extended release cannabis capsules that provide symptom relief for up to 12 hours. Wana Brands is the No. 1 ranked edibles brand in sales revenue in the highly competitive Colorado market according to BDS Analytics (2016 Brand Share Report). Wana products are also available in Oregon and Nevada with more markets readying for launch. For more information, visit www.wanabrands.com. Become a fan of Wana on Facebook, Instagram, LinkedIn and Twitter.
About AltMed Enterprises – Alternative Medical Enterprises, LLC, doing business as AltMed Enterprises, is a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.